(RTTNews) - SeaStar Medical Holding Corp. (ICU) on Thursday said that critically ill pediatric patients with sepsis-associated acute kidney injury who received QUELIMMUNE (SCD-PED) therapy had significantly higher survival rates than a historical comparison group in the primary a
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.